Report Detail

Request for Sample of this report

Other Global Dry Powder Inhaler Device Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • RnM3061801
    • |
  • 06 March, 2019
    • |
  • Global
    • |
  • 120 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Other

A dry powder inhaler (DPI) is a device that delivers medication to the lungs in the form of a dry powder. DPIs are commonly used to treat respiratory diseases such as asthma, bronchitis, emphysema and COPD although DPIs (such as inhalable insulin Afrezza) have also been used in the treatment of diabetes mellitus.

Scope of the Report:
The global total sales of dry powder inhaler device is nearly 49674 K units in 2015.
As a high tech industry, the manufacturing technology of Dry Powder Inhaler Device is mature but only these international giants can supply the high-end products with excellent performance. There is still a core technical barrier.
Today, the price of Dry Powder Inhaler Device is lower than past years. The reason for this downward trend of price is the development of technology and the price fluctuations of raw materials. In future, the price would go down continuously and slowly.
The worldwide market for Dry Powder Inhaler Device is expected to grow at a CAGR of roughly 4.9% over the next five years, will reach 820 million US$ in 2024, from 640 million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Dry Powder Inhaler Device in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
GlaxoSmithKline
AstraZeneca
Boehringer Ingelheim
Chiesi
Cipla
3M
Hovione
Mannkind
Meda
Novartis
Schering/Merck
Teva
Vectura

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Single Dose
Multi-dose

Market Segment by Applications, can be divided into
Asthma
COPD
Other

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Dry Powder Inhaler Device product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Dry Powder Inhaler Device, with price, sales, revenue and global market share of Dry Powder Inhaler Device in 2017 and 2018.
Chapter 3, the Dry Powder Inhaler Device competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Dry Powder Inhaler Device breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Dry Powder Inhaler Device market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Dry Powder Inhaler Device sales channel, distributors, customers, research findings and conclusion, appendix and data source.


Table of Contents

    1 Market Overview

    • 1.1 Dry Powder Inhaler Device Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 Single Dose
      • 1.2.2 Multi-dose
    • 1.3 Market Analysis by Applications
      • 1.3.1 Asthma
      • 1.3.2 COPD
      • 1.3.3 Other
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2014-2024)
        • 1.4.1.2 Canada Market States and Outlook (2014-2024)
        • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2014-2024)
        • 1.4.2.2 France Market States and Outlook (2014-2024)
        • 1.4.2.3 UK Market States and Outlook (2014-2024)
        • 1.4.2.4 Russia Market States and Outlook (2014-2024)
        • 1.4.2.5 Italy Market States and Outlook (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2014-2024)
        • 1.4.3.2 Japan Market States and Outlook (2014-2024)
        • 1.4.3.3 Korea Market States and Outlook (2014-2024)
        • 1.4.3.4 India Market States and Outlook (2014-2024)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
        • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
        • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
        • 1.4.4.5 Turkey Market States and Outlook (2014-2024)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 GlaxoSmithKline
      • 2.1.1 Business Overview
      • 2.1.2 Dry Powder Inhaler Device Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 GlaxoSmithKline Dry Powder Inhaler Device Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 AstraZeneca
      • 2.2.1 Business Overview
      • 2.2.2 Dry Powder Inhaler Device Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 AstraZeneca Dry Powder Inhaler Device Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Boehringer Ingelheim
      • 2.3.1 Business Overview
      • 2.3.2 Dry Powder Inhaler Device Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Boehringer Ingelheim Dry Powder Inhaler Device Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Chiesi
      • 2.4.1 Business Overview
      • 2.4.2 Dry Powder Inhaler Device Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Chiesi Dry Powder Inhaler Device Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Cipla
      • 2.5.1 Business Overview
      • 2.5.2 Dry Powder Inhaler Device Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Cipla Dry Powder Inhaler Device Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 3M
      • 2.6.1 Business Overview
      • 2.6.2 Dry Powder Inhaler Device Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 3M Dry Powder Inhaler Device Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Hovione
      • 2.7.1 Business Overview
      • 2.7.2 Dry Powder Inhaler Device Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Hovione Dry Powder Inhaler Device Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 Mannkind
      • 2.8.1 Business Overview
      • 2.8.2 Dry Powder Inhaler Device Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 Mannkind Dry Powder Inhaler Device Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.9 Meda
      • 2.9.1 Business Overview
      • 2.9.2 Dry Powder Inhaler Device Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 Meda Dry Powder Inhaler Device Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.10 Novartis
      • 2.10.1 Business Overview
      • 2.10.2 Dry Powder Inhaler Device Type and Applications
        • 2.10.2.1 Product A
        • 2.10.2.2 Product B
      • 2.10.3 Novartis Dry Powder Inhaler Device Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.11 Schering/Merck
      • 2.11.1 Business Overview
      • 2.11.2 Dry Powder Inhaler Device Type and Applications
        • 2.11.2.1 Product A
        • 2.11.2.2 Product B
      • 2.11.3 Schering/Merck Dry Powder Inhaler Device Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.12 Teva
      • 2.12.1 Business Overview
      • 2.12.2 Dry Powder Inhaler Device Type and Applications
        • 2.12.2.1 Product A
        • 2.12.2.2 Product B
      • 2.12.3 Teva Dry Powder Inhaler Device Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.13 Vectura
      • 2.13.1 Business Overview
      • 2.13.2 Dry Powder Inhaler Device Type and Applications
        • 2.13.2.1 Product A
        • 2.13.2.2 Product B
      • 2.13.3 Vectura Dry Powder Inhaler Device Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Dry Powder Inhaler Device Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

    • 3.1 Global Dry Powder Inhaler Device Sales and Market Share by Manufacturer (2017-2018)
    • 3.2 Global Dry Powder Inhaler Device Revenue and Market Share by Manufacturer (2017-2018)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Dry Powder Inhaler Device Manufacturer Market Share in 2018
      • 3.3.2 Top 6 Dry Powder Inhaler Device Manufacturer Market Share in 2018
    • 3.4 Market Competition Trend

    4 Global Dry Powder Inhaler Device Market Analysis by Regions

    • 4.1 Global Dry Powder Inhaler Device Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Dry Powder Inhaler Device Sales and Market Share by Regions (2014-2019)
      • 4.1.2 Global Dry Powder Inhaler Device Revenue and Market Share by Regions (2014-2019)
    • 4.2 North America Dry Powder Inhaler Device Sales and Growth Rate (2014-2019)
    • 4.3 Europe Dry Powder Inhaler Device Sales and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Dry Powder Inhaler Device Sales and Growth Rate (2014-2019)
    • 4.5 South America Dry Powder Inhaler Device Sales and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Dry Powder Inhaler Device Sales and Growth Rate (2014-2019)

    5 North America Dry Powder Inhaler Device by Country

    • 5.1 North America Dry Powder Inhaler Device Sales, Revenue and Market Share by Country
      • 5.1.1 North America Dry Powder Inhaler Device Sales and Market Share by Country (2014-2019)
      • 5.1.2 North America Dry Powder Inhaler Device Revenue and Market Share by Country (2014-2019)
    • 5.2 United States Dry Powder Inhaler Device Sales and Growth Rate (2014-2019)
    • 5.3 Canada Dry Powder Inhaler Device Sales and Growth Rate (2014-2019)
    • 5.4 Mexico Dry Powder Inhaler Device Sales and Growth Rate (2014-2019)

    6 Europe Dry Powder Inhaler Device by Country

    • 6.1 Europe Dry Powder Inhaler Device Sales, Revenue and Market Share by Country
      • 6.1.1 Europe Dry Powder Inhaler Device Sales and Market Share by Country (2014-2019)
      • 6.1.2 Europe Dry Powder Inhaler Device Revenue and Market Share by Country (2014-2019)
    • 6.2 Germany Dry Powder Inhaler Device Sales and Growth Rate (2014-2019)
    • 6.3 UK Dry Powder Inhaler Device Sales and Growth Rate (2014-2019)
    • 6.4 France Dry Powder Inhaler Device Sales and Growth Rate (2014-2019)
    • 6.5 Russia Dry Powder Inhaler Device Sales and Growth Rate (2014-2019)
    • 6.6 Italy Dry Powder Inhaler Device Sales and Growth Rate (2014-2019)

    7 Asia-Pacific Dry Powder Inhaler Device by Country

    • 7.1 Asia-Pacific Dry Powder Inhaler Device Sales, Revenue and Market Share by Country
      • 7.1.1 Asia-Pacific Dry Powder Inhaler Device Sales and Market Share by Country (2014-2019)
      • 7.1.2 Asia-Pacific Dry Powder Inhaler Device Revenue and Market Share by Country (2014-2019)
    • 7.2 China Dry Powder Inhaler Device Sales and Growth Rate (2014-2019)
    • 7.3 Japan Dry Powder Inhaler Device Sales and Growth Rate (2014-2019)
    • 7.4 Korea Dry Powder Inhaler Device Sales and Growth Rate (2014-2019)
    • 7.5 India Dry Powder Inhaler Device Sales and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Dry Powder Inhaler Device Sales and Growth Rate (2014-2019)

    8 South America Dry Powder Inhaler Device by Country

    • 8.1 South America Dry Powder Inhaler Device Sales, Revenue and Market Share by Country
      • 8.1.1 South America Dry Powder Inhaler Device Sales and Market Share by Country (2014-2019)
      • 8.1.2 South America Dry Powder Inhaler Device Revenue and Market Share by Country (2014-2019)
    • 8.2 Brazil Dry Powder Inhaler Device Sales and Growth Rate (2014-2019)
    • 8.3 Argentina Dry Powder Inhaler Device Sales and Growth Rate (2014-2019)
    • 8.4 Colombia Dry Powder Inhaler Device Sales and Growth Rate (2014-2019)

    9 Middle East and Africa Dry Powder Inhaler Device by Countries

    • 9.1 Middle East and Africa Dry Powder Inhaler Device Sales, Revenue and Market Share by Country
      • 9.1.1 Middle East and Africa Dry Powder Inhaler Device Sales and Market Share by Country (2014-2019)
      • 9.1.2 Middle East and Africa Dry Powder Inhaler Device Revenue and Market Share by Country (2014-2019)
    • 9.2 Saudi Arabia Dry Powder Inhaler Device Sales and Growth Rate (2014-2019)
    • 9.3 Turkey Dry Powder Inhaler Device Sales and Growth Rate (2014-2019)
    • 9.4 Egypt Dry Powder Inhaler Device Sales and Growth Rate (2014-2019)
    • 9.5 Nigeria Dry Powder Inhaler Device Sales and Growth Rate (2014-2019)
    • 9.6 South Africa Dry Powder Inhaler Device Sales and Growth Rate (2014-2019)

    10 Global Dry Powder Inhaler Device Market Segment by Type

    • 10.1 Global Dry Powder Inhaler Device Sales, Revenue and Market Share by Type (2014-2019)
      • 10.1.1 Global Dry Powder Inhaler Device Sales and Market Share by Type (2014-2019)
      • 10.1.2 Global Dry Powder Inhaler Device Revenue and Market Share by Type (2014-2019)
    • 10.2 Single Dose Sales Growth and Price
      • 10.2.1 Global Single Dose Sales Growth (2014-2019)
      • 10.2.2 Global Single Dose Price (2014-2019)
    • 10.3 Multi-dose Sales Growth and Price
      • 10.3.1 Global Multi-dose Sales Growth (2014-2019)
      • 10.3.2 Global Multi-dose Price (2014-2019)

    11 Global Dry Powder Inhaler Device Market Segment by Application

    • 11.1 Global Dry Powder Inhaler Device Sales Market Share by Application (2014-2019)
    • 11.2 Asthma Sales Growth (2014-2019)
    • 11.3 COPD Sales Growth (2014-2019)
    • 11.4 Other Sales Growth (2014-2019)

    12 Dry Powder Inhaler Device Market Forecast (2019-2024)

    • 12.1 Global Dry Powder Inhaler Device Sales, Revenue and Growth Rate (2019-2024)
    • 12.2 Dry Powder Inhaler Device Market Forecast by Regions (2019-2024)
      • 12.2.1 North America Dry Powder Inhaler Device Market Forecast (2019-2024)
      • 12.2.2 Europe Dry Powder Inhaler Device Market Forecast (2019-2024)
      • 12.2.3 Asia-Pacific Dry Powder Inhaler Device Market Forecast (2019-2024)
      • 12.2.4 South America Dry Powder Inhaler Device Market Forecast (2019-2024)
      • 12.2.5 Middle East and Africa Dry Powder Inhaler Device Market Forecast (2019-2024)
    • 12.3 Dry Powder Inhaler Device Market Forecast by Type (2019-2024)
      • 12.3.1 Global Dry Powder Inhaler Device Sales Forecast by Type (2019-2024)
      • 12.3.2 Global Dry Powder Inhaler Device Market Share Forecast by Type (2019-2024)
    • 12.4 Dry Powder Inhaler Device Market Forecast by Application (2019-2024)
      • 12.4.1 Global Dry Powder Inhaler Device Sales Forecast by Application (2019-2024)
      • 12.4.2 Global Dry Powder Inhaler Device Market Share Forecast by Application (2019-2024)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Summary:
      Get latest Market Research Reports on Dry Powder Inhaler Device . Industry analysis & Market Report on Dry Powder Inhaler Device is a syndicated market report, published as Global Dry Powder Inhaler Device Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Dry Powder Inhaler Device market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      		$3,480.00
      		$5,220.00
      		$6,960.00
      		2,773.56
      		4,160.34
      		5,547.12
      		3,236.40
      		4,854.60
      		6,472.80
      		532,022.40
      		798,033.60
      		1,064,044.80
      		290,336.40
      		435,504.60
      		580,672.80
      Credit card Logo
      Sample Question Discount Download PDF

      Related Reports

      Reason to Buy

      • Trusted By Leaders

        Top executives from leading companies purchase research reports from us. 

      • Shop With Confidence

        We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

      • Customer Centric

        Need assistance related to your research requirements? We are just a phone call or an email away.

      • Personalized Solutions

        Our experienced research specialists are here to help you locate the right reports for your need.

      • Secure Checkout

        Shop without being worried about safety & security of your transactions.
        •

      Request for Sample of this report

      Reports and Markets

      mcafree

      Contact Us

      +1-352-353-0818 (US)

      info@reportsandmarkets.com

      Support

      EMAIL US

      Newsletter

      KEEP UP TO DATE ON ALL THE LATEST REPORTS


      maxmind_logo